AMENDMENT NO. 1 TO MASTER SERVICES AGREEMENT (For All CRO Services)

Exhibit 10.162

AMENDMENT NO. 1

TO

MASTER SERVICES AGREEMENT

(For All CRO Services)

This Amendment (“Amendment No. 1”) is made between VistaGen Therapeutics, Inc., a Nevada corporation having an address at 000 Xxxxxxxx Xxxxxx, Xxxxx Xxx Xxxxxxxxx, Xxxxxxxxxx 00000 (“VistaGen”) and Allucent (formerly known as Cato Research Ltd.) a North Carolina corporation having an address at 0000 Xxxxxxxxxxx Xxx, Xxxxx 000, Xxxx, Xxxxx Xxxxxxxx 00000 (“Allucent”), and is effective as of June 23, 2022.

WHEREAS, VistaGen and Xxxxxxxx entered into a Master Services Agreement dated July 11, 2017 (the “Agreement”); and

WHEREAS, the parties wish to amend the Agreement to extend its term.

VistaGen and Xxxxxxxx therefore agree as follows:

AMENDMENT

1. The term of the Agreement shall be extended and continue until the later of July 31, 2027, or the expiration or termination of any Work Orders that are active as of that date.

2. The automatic renewal provision in Section 5.1 of the Agreement is deleted going forward as of the effective date of this Amendment No. 1.

Except as expressly provided in this Amendment No. 1, the Agreement remains unchanged and in full force and effect.

[Remainder of page intentionally left blank]

Each party is signing this agreement with the party’s authorized signature.

AGREED TO:			AGREED TO:
VISTAGEN THERAPEUTICS, INC.			ALLUCENT
By:	/s/ Xxxxx X. Xxxxx		By:	/s/ Xxxxxxx Xxxxxxx
Name:	Xxxxx X. Xxxxx, X.X.		Name:	Xxxxxxx Xxxxxxx
Title:	Chief Executive Officer		Title:	Chief Financial Officer
Date:	June 23, 2022		Date:	6/24/2022

Page 2 of 2